Screener
Elanco Animal Health Inc. ELAN Product Sales — Accounts Receivable
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001739104-26-000043
FAQ
- What is Elanco Animal Health Inc.'s product sales — accounts receivable?
- Elanco Animal Health Inc. (ELAN) reported product sales — accounts receivable of $131M in Q2 2026.
- How has Elanco Animal Health Inc.'s product sales — accounts receivable changed year-over-year?
- Elanco Animal Health Inc.'s product sales — accounts receivable increased by 10.1% year-over-year, from $119M to $131M.
- What is the long-term trend for Elanco Animal Health Inc.'s product sales — accounts receivable?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s product sales — accounts receivable has grown at a 8.7% compound annual growth rate (CAGR), from $329M to $460M.
- What does product sales — accounts receivable mean?
- This metric represents the net balance of trade receivables specifically attributable to the Product Sales segment after accounting for allowances for doubtful accounts. It measures the amount of revenue recognized from animal health product sales that has not yet been collected from customers. This figure is critical for assessing the credit quality of the customer base and the effectiveness of the company's collection processes within its primary business segment.
Ask your AI about Elanco Animal Health Inc.'s product sales — accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude